Chandrajit P. Raut named Surgeon-in-Chief for Dana-Farber Cancer Institute

Chandrajit P. Raut, MD, MSc, has been named Surgeon-in-Chief for Dana-Farber Cancer Institute. 

As Surgeon-in-Chief for Dana-Farber, Raut will be responsible for the staff and programs of the oncology surgical department through the current collaboration with Brigham and Women's Hospital (BWH). He will work closely with faculty and staff to ensure that the highest standards of quality and care are provided.

In addition to this role, Raut also serves as Chief of the Division of Surgical Oncology for BWH; Distinguished Chair for Cancer Care, Department of Surgery, BWH; Surgery Director, Center for Sarcoma and Bone Oncology, Dana-Farber; and Professor of Surgery, Harvard Medical School.

"I congratulate Chandrajit Raut on his new role. His leadership and experience embodies our vision and will be valuable as we continue to partner in providing expert care for the patients who depend on us," said Laurie H. Glimcher, MD, president and CEO, Dana-Farber Cancer Institute.

Raut is a graduate of Stanford University, the University of Oxford, and Harvard Medical School. He completed his general surgery residency at Massachusetts General Hospital and a surgical oncology fellowship at MD Anderson Cancer Center.

He is a committed clinician who specializes in the multidisciplinary care of patients with soft tissue sarcoma. Raut is a prolific researcher who has received two National Institutes of Health R01 grants to develop innovative chemotherapy-eluting films to reduce surgical bed tumor local recurrence rates. Additionally, he has served as Co-Principal Investigator or institutional Principal Investigator on several U.S. and international phase 2 or phase 3 clinical trials evaluating therapies in various sarcomas.

Raut is the former program director of the Mass General Brigham/Dana-Farber Complex General Surgical Oncology Fellowship program at Harvard Medical School. He serves as section editor for Sarcoma in the journals Cancer and Surgical Oncology Insights and is co-chair of the Alliance for Clinical Trials in Oncology Surgery Committee. He has authored over 280 papers and over 30 book chapters.